Specify a stock or a cryptocurrency in the search bar to get a summary
Shedir Pharma Group
SHEShedir Pharma Group S.p.A., through its subsidiaries, engages in the research, formulation, development, and marketing of nutraceuticals, dermocosmetics, medical devices, and pharmaceutical products in Italy. It provides products for andrological, cardiovascular, dermatological, hematological, energy, gastrointestinal, gynecological, metabolic, neurological, dental, ophthalmic, osteoarticular, otologic, respiratory, and trichological diseases. The company offers its products through a network of sales agents, wholesalers, and pharmacies. Shedir Pharma Group S.p.A. was founded in 2008 and is based in Naples, Italy. Address: Via Bagnulo 95, Naples, NA, Italy, 80063
Analytics
WallStreet Target Price
7.69 EURP/E ratio
9.1321Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SHE
Dividend Analytics SHE
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
41 %Dividend History SHE
Stock Valuation SHE
Financials SHE
Results | 2019 | Dynamics |